Zobrazeno 1 - 10
of 62
pro vyhledávání: '"William Romero"'
Autor:
Melinda J. Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, Michael J. Cork, Lawrence F. Eichenfield, Eric L. Simpson, Athanasios Tsianakas, Urs Kerkmann, Claire Feeney, William Romero
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 8, Pp 2285-2296 (2024)
Abstract Abrocitinib, an oral, once-daily, Janus kinase (JAK) 1-selective inhibitor, is approved for the treatment of adults and adolescents with moderate-to-severe atopic dermatitis (AD). Abrocitinib has shown rapid and sustained efficacy in phase 3
Externí odkaz:
https://doaj.org/article/9fab2eaae3014f6bb0a226938e458120
Autor:
Jacob P. Thyssen, Dan Henrohn, Maureen P. Neary, Kirk Geale, Alexander R. Dun, Gustaf Ortsäter, Ingrid Lindberg, Anna De Geer, Petra Neregård, Amy Cha, Joseph C. Cappelleri, William Romero, Laura vonKobyletzki
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 1, Pp 128-141 (2024)
Abstract Background Atopic dermatitis (AD) is a chronic inflammatory skin disease that has been shown to be associated with allergic comorbidities. However, studies examining comorbidities in patients with AD are incomplete, which may contribute to s
Externí odkaz:
https://doaj.org/article/682733713428468e82be9f706d9b21ba
Autor:
Gustaf Ortsäter, Anna De Geer, Alexander Rieem Dun, Kirk Geale, Ingrid Lindberg, Jacob Pontoppidan Thyssen, Laura B. vonKobyletzki, Alexandra Metsini, Dan Henrohn, Petra Neregård, Amy Cha, Joseph C. Cappelleri, William Romero, Maureen P. Neary
Publikováno v:
JEADV Clinical Practice, Vol 1, Iss 4, Pp 326-343 (2022)
Abstract Background Atopic dermatitis (AD) is a common inflammatory skin disease while the economic burden of AD by severity is not adequately understood. Objective To estimate the societal economic burden and to identify cost determinants of AD. Met
Externí odkaz:
https://doaj.org/article/885f76a34f1541309327f1bf780ec2de
Autor:
Marco Boeri, Jessie Sutphin, Brett Hauber, Joseph C. Cappelleri, William Romero, Marco Di Bonaventura
Publikováno v:
Journal of Dermatological Treatment, Vol 33, Iss 3, Pp 1449-1458 (2022)
Objectives To identify meaningful treatment attributes and quantify patient preferences for attributes of systemic atopic dermatitis (AD) treatments. Materials and methods Qualitative interviews were conducted with adults with moderate-to-severe AD (
Externí odkaz:
https://doaj.org/article/fa20c3454d654feba3b2d9b220053905
The vector $U$-bosons, or so called 'dark photons', are one of the possible candidates for the dark matter mediators. We present a procedure to derive theoretical constraints on the upper limit of kinetic mixing parameter $\epsilon^2(M_U)$ from heavy
Externí odkaz:
http://arxiv.org/abs/2409.20141
Autor:
Simon de Lusignan, Andrew R Thompson, Matthew Harries, Christos Tziotzios, Abby E Macbeth, Susan Holmes, Wing Sin Chiu, William Romero Gallardo, Andrew G Messenger
Publikováno v:
BMJ Open, Vol 11, Iss 11 (2021)
Introduction Alopecia areata (AA) is a common cause of immune-mediated non-scarring hair loss. Links between AA and common mental health, autoimmune and atopic conditions, and common infections have previously been described but remain incompletely e
Externí odkaz:
https://doaj.org/article/0e2508d70679492aa9ba6e9052e8371d
Autor:
Claudia de la Cruz F, Cristián Navarrete D, Daniela Majerson G, William Romero G, Angie Vergara R, Sergio González B
Publikováno v:
Revista Chilena de Obstetricia y Ginecología, Vol 77, Iss 1, Pp 64-71 (2012)
La embarazada es susceptible a cambios en la piel y fanéreos que pueden ser fisiológicos como patológicos. El reconocimiento de estas entidades es fundamental para un correcto manejo. La clasificación y nomenclatura de las dermatosis del embarazo
Externí odkaz:
https://doaj.org/article/424986e5193a4873b5a541b61e8c7fd7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Manuel Huerfáno Castro, Mario Andrés Mercado Díaz, Yuri Valentina Pinzón Martínez, Maria Jose Vargas, William Romero Castellanos
Publikováno v:
Acta Colombiana de Cuidado Intensivo. 22:75-80
Resumen En el paciente criticamente enfermo, la falla hepatica aguda sobre cronica (FHAC) representa un reto clinico dado que las alternativas terapeuticas son limitadas, usualmente ineficaces y se enfocan en un abordaje sintomatico. El trasplante he
Autor:
Eric L Simpson, Jonathan I Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M Hoffmeister, Alexander Egeberg, Hernan Valdez, Haiyun Fan, Saleem A Farooqui, Gary Chan, Justine Alderfer, William Romero, Susan Johnson
Publikováno v:
British Journal of Dermatology. 188
Abrocitinib is an oral Janus kinase 1 inhibitor with demonstrated efficacy in moderate-to-severe atopic dermatitis (AD). To evaluate the long-term safety profile of abrocitinib and provide relevant information for practitioners. Data from patients wh